Nordex 9-month Net Loss Narrows, Sales Climb; Revises FY21 Outlook - Quick Facts

Nordex Group (NRDXF.PK), a wind turbines manufacturer, reported Monday that its nine-month consolidated net loss narrowed to 103.7 million euros from last year's loss of 107.5 million euros.

EBIT margin, adjusted for PPA, was negative 0.1 percent, compared to negative 0.8 percent last year.

Earnings before interest, taxes, depreciation and amortization or EBITDA rose to 100.7 million euros from last year's 70.8 million euros. This resulted in an EBITDA margin of 2.5 percent, up from 2.2 percent a year ago.

The financial performance was significantly impacted by the sharp rise in commodity and shipping costs.

Sales climbed 25 percent to 3.96 billion euros from last year's 3.17 billion euros. Gross revenue was 3.58 billion euros, up 15.4 percent from 3.11 billion euros a year ago.

The sales growth is mainly attributable to the significant increase in installation figures and the expanded production output in the Projects segment.

Installations grew 46 percent to 4.9 GW in the first nine months. Order book was consistently strong at 8.0 billion euros.

Looking ahead, the company revised its guidance for 2021, and now expects to post consolidated sales of between 5.0 billion euros and 5.2 billion euros and an EBITDA margin of around 1 percent due to a highly volatile macro environment.

The company previously expected consolidated sales of 4.7 billion - 5.2 billion euros, and an EBITDA margin of 4.0 - 5.5 percent.

The company expects to overcome the current challenges and continues to aim for its strategic target of achieving an EBITDA margin of 8 percent in the medium term, once the external markets have overall stabilized and the period of cost and sales pricing adjustments is over.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT